Do disease-modifying antirheumatic drugs and non-steroidal anti-inflammatory drugs increase the burden on ankylosing spondylitis patients with mild-moderate COVID-19? evidence from a retrospective cohort study.

Front Pharmacol · 2023 · PMC10642246 · PMID 37964869

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

In consideration of the possibility of confounding bias and the borderline significant effect of NSAIDs, the interpretation of this finding should be cautious and it needs re-examination in further research.

also in 11,409 other papers

borderline significanceno p-value reported

The exception was patients on NSAIDs monotherapy, which presented a subtly worsening effect on symptom burden with borderline significance (RRa 1.22, 95% CI: 1.01–1.46).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.